N. Westhoff

Papers

1

Total Citations

2

H-Index

1

About

N. Westhoff is a clinical researcher whose work centers on surgical innovation in urologic oncology, with a particular focus on improving outcomes after robotic-assisted radical prostatectomy. Their most notable contribution is the design and execution of the PELYCAN study, a landmark phase III randomised controlled adaptive trial that compared a peritoneal flap technique against standard care for preventing lymphocele formation following pelvic lymph node dissection. This work addresses a critical postoperative complication, offering evidence-based guidance for surgeons and directly impacting patient recovery. While the PELYCAN study has garnered early citations since its 2023 publication, Westhoff’s broader impact lies in advancing adaptive trial methodologies within surgical research, demonstrating how flexible study designs can accelerate the evaluation of intraoperative interventions. Their research bridges the gap between technical surgical innovation and rigorous clinical evidence, making them a key figure in evidence-based urologic surgery. Westhoff’s commitment to high-quality trial design and patient-centered outcomes positions them as an emerging leader in the field, with future work likely to further refine surgical techniques and reduce complications.

Research Focus

Key Achievements

1
H-Index
1
Papers
2
Total Citations
2
Avg Citations/Paper
🏆 Most Cited Paper
A randomised controlled adaptive design phase III trial comparing a peritoneal flap versus no flap for lymphocele prevention after robotic-assisted radical prostatectomy with pelvic lymph node dissection: The PELYCAN study
2 citations · 2023
📈 Most Prolific Year: 2023 (1 Papers)
🤝 Key Collaborators: 11

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago